Raphas

Seoul, South Korea Founded: 2006 • Age: 20 yrs Listed
Microneedle technology is developed for cosmetics and medical applications.

About Raphas

Raphas is a publicly listed company based in Seoul (South Korea) founded in 2006. Microneedle technology is developed for cosmetics and medical applications. The company has 100 employees. Its focus areas include Life Sciences, Drug Delivery, Patches and Microneedle Patch.

Company details

Developer of microneedle technology for cosmetics and medical applications. This company manufactures microneedles for transdermal drug delivery and produces cosmetic and food products utilizing this technology. The company holds various certifications and approvals for its products in multiple regions. Its offerings include a cosmetic brand featuring microneedle technologies and a brand of health-focused food products.

  • Headquarters Seoul, South Korea
  • Employees 100
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website raphas.com
  • Legal Name Raphas Co. Ltd.
Key Metrics
  • Annual Revenue
    $21.46 M (USD)
    13.86
    as on Dec 31, 2025
  • Net Profit
    -$2.98 M (USD)
    9.58
    as on Dec 31, 2025
  • EBITDA
    $207.89 K (USD)
    61.96
    as on Dec 31, 2025
  • Investors
  • Employee Count
    100

Funding Insights of Raphas

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Raphas with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2016Seed––
Valuation history

1 investors in total: 1 institutional.

Investors in Raphas

Raphas has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include KIC Europe.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
KIC Europe is focused on fostering innovation between Korea and the EU.
kiceurope.euBerlin, Germany
Premium access

Investor details for Raphas

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of Raphas

Raphas is a publicly listed company on the KRX with ticker symbol 214260 in South Korea, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date11 Nov 2019
  • Listed onKRX: 214260
  • Listed entityRAPHAS CO. LTD.
  • Exchange sectorProcess industries
  • ISINKR7214260002
  • Share price7,140.00 KRW (+0.56% on the day) · 2026-10-14
  • Market capitalisation59,700,083,923.00 KRW
  • Price to earnings200.0
  • EPS (diluted, trailing year)-651.66 KRW
  • Volume (last session)4,231

Financials of Raphas

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202530.99B KRW-4.31B KRW300.2M KRW
202427.22B KRW-4.77B KRW185.4M KRW
202327.94B KRW-8.80B KRW-800.5M KRW
202223.64B KRW-8.51B KRW-3.72B KRW
202120.34B KRW4.93B KRW198.3M KRW
Premium access

Detailed financial statements for Raphas

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Raphas

3 dated milestones of Raphas across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Raphas is founded.
  2. Funding First funding round.
  3. IPO Lists on the stock exchange (IPO).

Web traffic of Raphas

The website of Raphas (raphas.com) receives about 7.1K visits a month and ranks #2,860,048 among all websites worldwide, #3,832 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    7.1K

    ▼ 2.6% vs previous month

  • Unique visitors
    3.2K

    per month

  • Global rank
    #2,860,048

    among all websites

  • Category rank
    #3,832

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Raphas. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
pharmnews.com
100%
#274,610View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Raphas

Premium access

Complete news archive for Raphas

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raphas

Raphas was founded in 2006 and raised its 1st funding round 10 years after it was founded.

Raphas is headquartered in Seoul, South Korea.

Raphas has 100 employees.

Annual revenue of Raphas is $21.46M as on Dec 31, 2025.

Developer of microneedle technology for cosmetics and medical applications. This company manufactures microneedles for transdermal drug delivery and produces cosmetic and food products utilizing this technology. The company holds various certifications and approvals for its products in multiple regions. Its offerings include a cosmetic brand featuring microneedle technologies and a brand of health-focused food products.

Yes, Raphas is publicly traded on KRX under the ticker symbol 214260.

Raphas has 1 investor. Key investors include KIC Europe.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available